BRPI0810878A2 - Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas. - Google Patents

Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas.

Info

Publication number
BRPI0810878A2
BRPI0810878A2 BRPI0810878-1A2A BRPI0810878A BRPI0810878A2 BR PI0810878 A2 BRPI0810878 A2 BR PI0810878A2 BR PI0810878 A BRPI0810878 A BR PI0810878A BR PI0810878 A2 BRPI0810878 A2 BR PI0810878A2
Authority
BR
Brazil
Prior art keywords
polyeletroly
particules
particulars
pharmaceutical formulations
formulations containing
Prior art date
Application number
BRPI0810878-1A2A
Other languages
English (en)
Inventor
Cecile Bonnet Gonnet
Frederic Checot
You-Ping Chan
Olivier Breyne
Original Assignee
Flamel Tech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Tech Sa filed Critical Flamel Tech Sa
Publication of BRPI0810878A2 publication Critical patent/BRPI0810878A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0810878-1A2A 2007-05-03 2008-05-05 Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas. BRPI0810878A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0703187A FR2915684B1 (fr) 2007-05-03 2007-05-03 Particules a base de polyelectrolytes et de principe actif a liberation modifiee et formulations pharmaceutiques contenant ces particules
PCT/EP2008/055505 WO2008135561A1 (fr) 2007-05-03 2008-05-05 Particules a base de polyelectrolytes et de principe actif a liberation modifiee et formulations pharmaceutiques contenant ces particules

Publications (1)

Publication Number Publication Date
BRPI0810878A2 true BRPI0810878A2 (pt) 2014-10-29

Family

ID=38787100

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810878-1A2A BRPI0810878A2 (pt) 2007-05-03 2008-05-05 Partículas à base de polieletrólitos e de princípio ativo de liberação modificada e formulações farmacêuticas contendo estas partículas.

Country Status (12)

Country Link
US (1) US8481019B2 (pt)
EP (1) EP2155173A1 (pt)
JP (1) JP2010526040A (pt)
KR (1) KR20100017574A (pt)
CN (1) CN101674814B (pt)
AU (1) AU2008248602B2 (pt)
BR (1) BRPI0810878A2 (pt)
CA (1) CA2685855A1 (pt)
FR (1) FR2915684B1 (pt)
IL (1) IL201689A (pt)
MX (1) MX2009011815A (pt)
WO (1) WO2008135561A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110150837A1 (en) * 2009-12-23 2011-06-23 Flamel Technologies Amphiphilic polymer functionalized by methionine
FR2954325B1 (fr) 2009-12-23 2012-02-03 Flamel Tech Sa Polymere amphiphile fonctionnalise par la methionine
FR2968993B1 (fr) * 2010-12-17 2012-12-28 Flamel Tech Sa Nanoparticules comportant au moins un actif et au moins deux polyelectrolytes
FR2968994B1 (fr) 2010-12-17 2012-12-28 Flamel Tech Sa Procede de preparation de nanoparticules
EP2814461B1 (fr) * 2012-01-09 2019-07-24 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide substitue

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786098B1 (fr) 1998-11-20 2003-05-30 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
FR2801226B1 (fr) 1999-11-23 2002-01-25 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2855521B1 (fr) 2003-05-28 2005-08-05 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement h ydrophobe et leurs applications notamment therapeutiques.
FR2860516B1 (fr) 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
IL162390A0 (en) * 2004-06-07 2005-11-20 Medigus Ltd Multipurpose endoscopy suite
FR2873704B1 (fr) * 2004-07-30 2006-12-08 Flamel Technologies Sa Polyaminoacides fonctionnalises par des greffons hydrophobes portant une charge anionique et leurs applications notamment therapeutiques
FR2881140B1 (fr) * 2005-01-27 2007-04-06 Flamel Technologies Sa Copolyhydroxyalkylglutamines fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2892725B1 (fr) 2005-10-31 2011-03-04 Flamel Tech Sa Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques
FR2902007B1 (fr) * 2006-06-09 2012-01-13 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques
FR2915748B1 (fr) 2007-05-03 2012-10-19 Flamel Tech Sa Acides polyglutamiques fonctionnalises par des groupes cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques

Also Published As

Publication number Publication date
MX2009011815A (es) 2009-11-13
US20090011039A1 (en) 2009-01-08
KR20100017574A (ko) 2010-02-16
FR2915684A1 (fr) 2008-11-07
JP2010526040A (ja) 2010-07-29
IL201689A (en) 2013-08-29
US8481019B2 (en) 2013-07-09
CA2685855A1 (fr) 2008-11-13
WO2008135561A1 (fr) 2008-11-13
AU2008248602B2 (en) 2012-07-26
EP2155173A1 (fr) 2010-02-24
AU2008248602A1 (en) 2008-11-13
FR2915684B1 (fr) 2011-01-14
IL201689A0 (en) 2010-05-31
CN101674814B (zh) 2013-10-16
CN101674814A (zh) 2010-03-17

Similar Documents

Publication Publication Date Title
CU20080052A7 (es) Formas de presentación farmacéutica sólidas de administración oral con liberación rápida de principio activo
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI0908596A2 (pt) formulação e composição farmacêutica de liberação prolongada
BRPI0811188A2 (pt) Composições fosfolipídicas para cuidados de lentes de contato e conservação de composições farmacêuticas.
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DE602006004731D1 (de) Trockengranulierungzusammensetzung enthaltend Emtricitabine und Tenofovir DF
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0821732A2 (pt) Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
BRPI0820381A2 (pt) Formulações farmacêuticas
NO20075628L (no) Farmasøytiske formuleringer
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
DK1940364T3 (da) Kapselformulering af pirfenidon og farmaceutisk acceptable excipienser
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
BRPI0820665A2 (pt) compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos
BR112012013148A2 (pt) formulação farmacêutica e uso
BRPI0917444A2 (pt) composições farmacêuticas de retenção gástrica para o tratamento e prevenção de doenas do snc
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]